Targeted Shiga toxin-drug conjugates prepared via Cu-free click chemistry

Bioorg Med Chem. 2015 Nov 15;23(22):7150-7. doi: 10.1016/j.bmc.2015.10.010. Epub 2015 Oct 8.

Abstract

The main drawback of the anticancer chemotherapy consists in the lack of drug selectivity causing severe side effects. The targeted drug delivery appears to be a very promising strategy for controlling the biodistribution of the cytotoxic agent only on malignant tissues by linking it to tumor-targeting moiety. Here we exploit the natural characteristics of Shiga toxin B sub-unit (STxB) as targeting carrier on Gb3-positive cancer cells. Two cytotoxic conjugates STxB-doxorubicin (STxB-Doxo) and STxB-monomethyl auristatin F (STxB-MMAF) were synthesised using copper-free 'click' chemistry. Both conjugates were obtained in very high yield and demonstrated strong tumor inhibition activity in a nanomolar range on Gb3-positive cells.

Keywords: Auristatin; Copper-free click; Doxorubicin; Shiga toxin; Targeted drug delivery.

MeSH terms

  • Antibodies / immunology
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity
  • Biological Transport
  • Cell Survival / drug effects
  • Click Chemistry*
  • Copper / chemistry
  • Doxorubicin / chemistry*
  • Doxorubicin / toxicity
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry*
  • Drug Design
  • HT29 Cells
  • HeLa Cells
  • Humans
  • Microscopy, Confocal
  • Oligopeptides / chemistry*
  • Oligopeptides / toxicity
  • Shiga Toxin / chemistry*
  • Shiga Toxin / immunology
  • Shiga Toxin / metabolism

Substances

  • Antibodies
  • Antineoplastic Agents
  • Drug Carriers
  • Oligopeptides
  • monomethylauristatin F
  • Shiga Toxin
  • Copper
  • Doxorubicin